Erythropoietin Resistance in Anemia of Chronic Kidney Disease

The Effect of Human Recombinant Erythropoietin in Acute Renal Failure

NCT03102021 ·Status: COMPLETED ·Phase: PHASE2

Renal Prognosis in Chronic Kidney Disease Patients With Hyporesponsive Anemia to Erythropoiesis Stimulating Agents

NCT02136563 ·Status: COMPLETED

Efficacy & Safety Study of Recombinant Human Erythropoietin -Alpha, in Patients With Anemia of Chronic Renal Failure

NCT00399269 ·Status: COMPLETED ·Phase: PHASE3

Frequent, Low-Dose Erythropoietin A Mechanistic Approach to Mitigate Adverse Cardiovascular Effects of Erythropoietin

NCT03277183 ·Status: TERMINATED ·Phase: PHASE4

Prevalence of Erythropoiesis Stimulating Agents Hyporesponsiveness in Dialysis Patients in Assiut University Hospital

NCT06053866 ·Status: NOT_YET_RECRUITING

Effect of Erythropoiesis-Stimulating Agent Therapy in Patients Receiving Palliative Care of Chronic Kidney Disease

NCT03427801 ·Status: COMPLETED

A Study of PEG-EPO Injection (CHO Cells) for Maintenance Therapy of Patients With Renal Anemia .

NCT05629598 ·Status: UNKNOWN ·Phase: PHASE2

The Effect of Epoetin Alfa on Cardiac Function and Quality of Life in Patients With Early Renal ((Kidney) Disease

NCT00446576 ·Status: COMPLETED ·Phase: PHASE3

Study of the Safety and Efficacy of Roxadustat in the Treatment of Heart Failure With Chronic Kidney Disease and Anemia

NCT05691257 ·Status: UNKNOWN ·Phase: PHASE4

A Study of YPEG-rhEPO in Patients Suffered From Anemia Due to Chronic Kidney Disease

NCT04885647 ·Status: COMPLETED ·Phase: PHASE2

A Study to Observe the Number of Patients Who Develop Pure Red Cell Aplasia (PRCA, a Rare Form of Anemia) While Receiving Epoetin Alfa or Other Recombinant Erythropoietins

NCT00211029 ·Status: COMPLETED

Efficacy of Epoetin Alfa Deep Tank in Treatment of Anemia in Patients With Chronic Kidney Disease Receiving Hemodialysis

NCT00146224 ·Status: COMPLETED ·Phase: PHASE3

Erythropoietin Therapy in Patients With Chronic Renal Failure: A Study of Time Dependent Activity

NCT00744445 ·Status: COMPLETED ·Phase: PHASE2

Prospective Observational Study of Erythropoietin-Iron Interaction in Anemia of Renal Disease

NCT01719146 ·Status: COMPLETED

Surveillance Study to Estimate the Incidence of Pure Red Blood Cell Aplasia Among Patients With Chronic Kidney Failure

NCT00391287 ·Status: COMPLETED

Study to Assess the Efficacy and Safety of HX575 in the Treatment of Chemotherapy Associated Anemia in Cancer Patients

NCT00711958 ·Status: COMPLETED ·Phase: PHASE3

Study to Monitor the Incidence of Pure Red Cell Aplasia (PRCA) and/or Antibodies to Erythropoietin Among Participants Receiving Epoetin Alfa or Another Erythropoietin

NCT00210951 ·Status: COMPLETED

Evaluating Erythropoietin as an Indicator for Possible Kidney Injury After Cardiac Surgery

NCT01393418 ·Status: COMPLETED

Study of Erythropoietin to Treat Anemia Complicating Chronic Obstructive Pulmonary Disease

NCT00579046 ·Status: WITHDRAWN ·Phase: PHASE3

An Efficacy and Safety Study of Epoetin Alfa for Initiation and Maintenance Treatment of Patients With Anemia Associated With Chronic Kidney Disease

NCT00440557 ·Status: COMPLETED ·Phase: PHASE3

A Phase 3 Study of Efepoetin Alfa for Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis

NCT06466785 ·Status: RECRUITING ·Phase: PHASE3

Study of Epoetin Alfa to Treat Anemia After Kidney Transplantation

NCT01290328 ·Status: TERMINATED ·Phase: NA

Safety and Efficacy of Sustained Erythropoietin Therapy

NCT00542568 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study of the Efficacy of Darbepoetin Alfa in the Treatment of Renal Anemia

NCT00563446 ·Status: COMPLETED ·Phase: NA

Safety and Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on Dialysis

NCT00598442 ·Status: COMPLETED ·Phase: PHASE3